Skip to content

Author

Wen-Jun Shao

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Anlotinib suppresses homologous recombination via the E2F8-RAD51 axis to activate STING immunity and potentiate PARP inhibitor synthetic lethality in resistant small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that almost invariably acquires resistance to first-line platinum-based chemotherapy, leading to early relapse. PARP inhibitors (PARPi) hold theoretical potential for SCLC due to universal TP53/RB1 deletion, but their monotherapy activity has...

Wen-Jun Shao, Pei-Yan Zhao, Yang Tan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.